Form 4: Omada Health Director Jeryl Hilleman Acquires Restricted Stock Units
Insider Transaction Report
Omada Health, Inc. Director Jeryl L. Hilleman reported the acquisition of 376 restricted stock units (RSUs) on July 5, 2025, bringing her total direct beneficial ownership to 10,112 shares of Common Stock.
Summary
- Jeryl L. Hilleman, a Director of Omada Health, Inc. (OMDA), acquired 376 shares of Common Stock in the form of Restricted Stock Units (RSUs).
- The transaction occurred on July 5, 2025.
- These RSUs were granted under the Issuer's Non-Employee Director Compensation Program in lieu of retainer fees.
- Each RSU represents the right to receive one share of Common Stock.
- Following this transaction, Jeryl L. Hilleman directly beneficially owns 10,112 shares of Common Stock.
- The RSUs were acquired at a price of $0, indicating they are compensation rather than a cash purchase.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as it indicates increased insider ownership and a standard, non-dilutive (in terms of cash) compensation method for a director, aligning interests with shareholders. There are no negative implications from this specific transaction.
Positives
- The acquisition of 376 Restricted Stock Units by a director increases insider ownership, aligning management's interests with shareholders.
- The grant of RSUs as compensation for retainer fees is a common practice that conserves cash for the company.
Negatives
- No direct negatives are apparent from this Form 4 filing, as it reports a standard compensation-related transaction.
Future Outlook
NA
Industry Context
This Form 4 filing reflects a routine compensation event for a director in the healthcare technology sector. The use of Restricted Stock Units (RSUs) as part of director compensation is a common practice across various industries, including health tech, to align director incentives with long-term company performance and shareholder value.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy | The Restricted Stock Units were granted pursuant to the Issuer's Non-Employee Director Compensation Program, indicating an established policy for director remuneration. | NA | This reflects a standard corporate governance practice for compensating non-employee directors, aligning their interests with the company's long-term performance through equity awards. |
Stakeholder Impact
- Shareholders: Increased alignment of director's interests with shareholders due to equity ownership.
- Company: Cash conservation by using equity for director compensation instead of cash retainer fees.
Key Dates
| Date | Description |
|---|---|
| 07/05/2025 | Date of earliest transaction, when 376 Restricted Stock Units were acquired. |
| 07/08/2025 | Date the Form 4 was signed by Nathan Salha, Attorney-in-Fact for Jeryl L. Hilleman. |
Recommendation
holdKeywords
Omada Health, OMDA, Jeryl L. Hilleman, Director, Restricted Stock Units, RSUs, Insider Trading, SEC Form 4, Beneficial Ownership, Compensation Program
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.